476 related articles for article (PubMed ID: 35244787)
1. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies.
Cascella R; Bigi A; Cremades N; Cecchi C
Cell Mol Life Sci; 2022 Mar; 79(3):174. PubMed ID: 35244787
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies.
Bigi A; Cascella R; Cecchi C
Neural Regen Res; 2023 Nov; 18(11):2332-2342. PubMed ID: 37282450
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
Lam HT; Graber MC; Gentry KA; Bieschke J
Biochemistry; 2016 Feb; 55(4):675-85. PubMed ID: 26799377
[TBL] [Abstract][Full Text] [Related]
5. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
[TBL] [Abstract][Full Text] [Related]
6. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
Lashuel HA
Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
[TBL] [Abstract][Full Text] [Related]
7. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
Alam P; Bousset L; Melki R; Otzen DE
J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
[TBL] [Abstract][Full Text] [Related]
8. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of α-synuclein truncation in aggregation and disease.
Sorrentino ZA; Giasson BI
J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
[TBL] [Abstract][Full Text] [Related]
11. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
[TBL] [Abstract][Full Text] [Related]
12. Cellular models of alpha-synuclein toxicity and aggregation.
Delenclos M; Burgess JD; Lamprokostopoulou A; Outeiro TF; Vekrellis K; McLean PJ
J Neurochem; 2019 Sep; 150(5):566-576. PubMed ID: 31265132
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
Mehra S; Sahay S; Maji SK
Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
[TBL] [Abstract][Full Text] [Related]
14. α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly.
Oikawa T; Nonaka T; Terada M; Tamaoka A; Hisanaga S; Hasegawa M
J Biol Chem; 2016 Jul; 291(29):15046-56. PubMed ID: 27226637
[TBL] [Abstract][Full Text] [Related]
15. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
Henderson MX; Trojanowski JQ; Lee VM
Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
[TBL] [Abstract][Full Text] [Related]
17. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
18. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
Uversky VN
J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
[TBL] [Abstract][Full Text] [Related]
19. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
[TBL] [Abstract][Full Text] [Related]
20. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
